NM_206933.4(USH2A):c.2279_2280del (p.Asn760fs) AND Usher syndrome type 2A
- Germline classification:
- Pathogenic (1 submission)
- Last evaluated:
- Sep 18, 2017
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000625605.2
Allele description [Variation Report for NM_206933.4(USH2A):c.2279_2280del (p.Asn760fs)]
NM_206933.4(USH2A):c.2279_2280del (p.Asn760fs)
Condition(s)
-
RecName: Full=E3 ubiquitin-protein ligase UHRF1; AltName: Full=RING-type E3 ubiq...
RecName: Full=E3 ubiquitin-protein ligase UHRF1; AltName: Full=RING-type E3 ubiquitin transferase UHRF1; AltName: Full=Ubiquitin-like PHD and RING finger domain-containing protein 1; AltName: Full=Ubiquitin-like-containing PHD and RING finger domains protein 1gi|410591701|sp|E7EZF3.1|UHRF1_DANRProtein
-
Chain B, 16-mer peptide from Nuclear receptor coactivator 1
Chain B, 16-mer peptide from Nuclear receptor coactivator 1gi|1806061729|pdb|6KTN|BProtein
-
Bromouracil
Bromouracil5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutag...<br/>Year introduced: 1974(1971)MeSH
-
Flucytosine
FlucytosineA fluorinated cytosine analog that is used as an antifungal agent.<br/>Year introduced: 1987(1972)MeSH
-
Amobarbital
AmobarbitalA barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence w...<br/>MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Mar 4, 2023